Dysregulation of β-chemokines in the lungs of HIV-1-infected patients

被引:0
|
作者
Aung, H
McKenna, SM
Ketoff, NR
Jones, L
Wu, M
Hejal, R
Rich, EA
Toossi, Z
机构
[1] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA
[2] Vet Adm Med Ctr, Cleveland, OH 44106 USA
来源
关键词
MIP-1; alpha; beta; MCP-1; RANTES; CCR5;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The beta -chemokines, macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, monocyte chemotactic protein (MCP)-1 and regulated-on-activation normal T cell, expressed and secreted (RANTES) are not only chemotactic for mononuclear cells but may be important in suppression of HIV-1 replication through competitive binding to the chemokine receptor, CCR5, which is critical to viral entry. In this study, broncho alveolar cells (BACs) and autologous peripheral blood mononuclear cells (PBMCs) were obtained from HIV-1-infected participants who did not manifest clinical signs of lung disease with peripheral CD4 T-cell count > 200/mm(3) (n = 7, group with high CD4 count), or CD4 T-cell count < 200/mm3 (n = 12, group with low CD4 count), and from healthy study subjects (n = 5). The capacity to express beta -chemokines and CCR5 was assessed. Induction of MIP-1 alpha by lipopolysaccharide (LPS) in BAC of HIV-1-infected study subjects from the low CD4 group was less than BAC from healthy study subjects (p < .001), and also was less than in BACs from the group with a high CD4 group (p < .001). Moreover, the intracellular expression of MIP-1 alpha in LPS-induced monocytes of HIV-1-infected patients was significantly less than that from healthy study subjects (p < .01). In addition, spontaneous expression of mRNAs for CCR5 and MIP-la in BAC was significantly lower in HIV-1-infected patients compared with in healthy study subjects (p < .03 and p < .02, respectively). In contrast to the findings with MIP-1 alpha, LPS stimulated MCP-1 in BAC from the group of HIV-1-infected patients with high CD4 count was significantly higher than healthy study subjects (p < .001). These dysregulations in the ability to express beta -chemokines by BAC may be important in the progression of HIV-1 infection in the lung.
引用
收藏
页码:305 / 314
页数:10
相关论文
共 50 条
  • [1] Memory B cell dysregulation in HIV-1-infected individuals
    Carrillo, Jorge
    Negredo, Eugenia
    Puig, Jordi
    Manuel Molinos-Albert, Luis
    Luisa Rodriguez de la Concepcion, Maria
    Curriu, Marta
    Massanella, Marta
    Navarro, Jordi
    Crespo, Manel
    Vinets, Ester
    Milla, Fuensanta
    Clotet, Bonaventura
    Blanco, Julia
    [J]. AIDS, 2018, 32 (02) : 149 - 160
  • [2] Lipodystrophy in HIV-1-infected patients
    Domingo, P
    Pérez, A
    Torres, OH
    Montiel, JA
    Vázquez, G
    [J]. LANCET, 1999, 354 (9181): : 868 - 868
  • [3] Neuroimaging in the brain in HIV-1-infected patients
    Thurnher, Majda M.
    Post, M. Judith Donovan
    [J]. NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (01) : 93 - +
  • [4] Renal dysfunction in HIV-1-infected patients
    Jeffrey B. Kopp
    [J]. Current Infectious Disease Reports, 2002, 4 (5) : 449 - 460
  • [5] Pneumocystis pneumonia in HIV-1-infected patients
    Shibata, Satoshi
    Kikuchi, Toshiaki
    [J]. RESPIRATORY INVESTIGATION, 2019, 57 (03) : 213 - 219
  • [6] Liver transplantation in HIV-1-infected patients
    José M Miró
    [J]. Retrovirology, 7
  • [7] Liver transplantation in HIV-1-infected patients
    Miro, Jose M.
    [J]. RETROVIROLOGY, 2010, 7 : 8 - 8
  • [8] AUTOANTIBODIES TO NUCLEOSOMES IN HIV-1-INFECTED PATIENTS
    VIARD, JP
    CHABRE, H
    BACH, JF
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1994, 7 (12): : 1286 - 1287
  • [9] HIV-2-INFECTED PATIENTS SURVIVE LONGER THAN HIV-1-INFECTED PATIENTS
    WHITTLE, H
    MORRIS, J
    TODD, J
    CORRAH, T
    SABALLY, S
    BANGALI, J
    NGOM, PT
    ROLFE, M
    WILKINS, A
    [J]. AIDS, 1994, 8 (11) : 1617 - 1620
  • [10] Effectiveness of ezetimibe on hyperlipidaemia in HIV-1-infected patients
    von Lintig, FC
    Lee, D
    Patel, P
    Epp, J
    Barber, R
    Mathews, WC
    [J]. ANTIVIRAL THERAPY, 2004, 9 (06) : L48 - L49